These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2610723)

  • 1. Effect of simvastatin on receptor-dependent low density lipoprotein catabolism in normocholesterolemic human volunteers.
    Malmendier CL; Lontie JF; Delcroix C; Magot T
    Atherosclerosis; 1989 Dec; 80(2):101-9. PubMed ID: 2610723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W; Infante J; Wang SR; Infante R
    Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of simvastatin on receptor mediated metabolism of low density lipoprotein in guinea pigs.
    Matsunaga A; Sasaki J; Takada Y; Hidaka K; Arakawa K
    Atherosclerosis; 1991 Sep; 90(1):31-7. PubMed ID: 1665974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
    Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ
    Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial defective apolipoprotein B-100 (FDB): effect of simvastatin therapy on LDL-receptor binding.
    Mamotte CD; Sturm M; Foo JI; van Bockxmeer FM; Taylor RR
    Atherosclerosis; 1996 Aug; 125(1):103-10. PubMed ID: 8831932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of simvastatin on apoB metabolism and LDL subfraction distribution.
    Gaw A; Packard CJ; Murray EF; Lindsay GM; Griffin BA; Caslake MJ; Vallance BD; Lorimer AR; Shepherd J
    Arterioscler Thromb; 1993 Feb; 13(2):170-89. PubMed ID: 8427854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypocholesterolemic effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in the guinea pig: atorvastatin versus simvastatin.
    Conde K; Pineda G; Newton RS; Fernandez ML
    Biochem Pharmacol; 1999 Oct; 58(7):1209-19. PubMed ID: 10484079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of simvastatin on plasma lipid and lipoprotein concentrations and low-density lipoprotein metabolism in the nephrotic syndrome.
    Warwick GL; Packard CJ; Murray L; Grierson D; Stewart JP; Shepherd J; Boulton-Jones JM
    Clin Sci (Lond); 1992 Jun; 82(6):701-8. PubMed ID: 1320552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced cellular metabolism of very low density lipoprotein by simvastatin. A novel mechanism of action of HMG-CoA reductase inhibitors.
    Sehayek E; Butbul E; Avner R; Levkovitz H; Eisenberg S
    Eur J Clin Invest; 1994 Mar; 24(3):173-8. PubMed ID: 8033951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual effect of lovastatin and simvastatin on LDL-macrophage interaction.
    Aviram M; Keidar S; Brook GJ
    Eur J Clin Chem Clin Biochem; 1991 Oct; 29(10):657-64. PubMed ID: 1764540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones.
    Ide H; Fujiya S; Aanuma Y; Agishi Y
    Clin Ther; 1990; 12(5):410-20. PubMed ID: 2268863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production, and decrease in particle affinity for the receptor. Results from a novel triple-tracer approach.
    Berglund L; Witztum JL; Galeano NF; Khouw AS; Ginsberg HN; Ramakrishnan R
    J Lipid Res; 1998 Apr; 39(4):913-24. PubMed ID: 9555954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
    Yu L; Qiu S; Genest J
    Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of hypercholesterolaemia, simvastatin and dietary fat on the low density lipoprotein receptor of unstimulated mononuclear cells.
    Roach PD; Hosking J; Clifton PM; Bais R; Kusenic B; Coyle P; Wight MB; Thomas DW; Nestel PJ
    Atherosclerosis; 1993 Nov; 103(2):245-54. PubMed ID: 8292099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of cyclosporine-inhibited low-density lipoprotein receptor activity in HepG2 cells by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    al Rayyes O; Wallmark A; Florén CH
    Hepatology; 1997 Apr; 25(4):991-4. PubMed ID: 9096609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin-induced decrease in the transfer of cholesterol esters from high density lipoproteins to very low and low density lipoproteins in normolipidemic subjects.
    Ahnadi CE; Berthezène F; Ponsin G
    Atherosclerosis; 1993 Mar; 99(2):219-28. PubMed ID: 8503950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effect of simvastatin on lipoprotein cholesteryl ester metabolism in normocholesterolemic volunteers.
    Magot T; Malmendier CL; Ouguerram K; Lontie JF; Lutton C
    Clin Chim Acta; 1991 Jan; 196(1):59-68. PubMed ID: 2022059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia.
    Bard JM; Luc G; Douste-Blazy P; Drouin P; Ziegler O; Jacotot B; Dachet C; De Gennes JL; Fruchart JC
    Eur J Clin Pharmacol; 1989; 37(6):545-50. PubMed ID: 2693115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen increases low-density lipoprotein receptor-independent catabolism of apolipoprotein B in hyperlipidemic rabbits.
    Colvin PL
    Metabolism; 1996 Jul; 45(7):889-96. PubMed ID: 8692027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.